Cargando…

Sepsis: Pathogenesis, Biomarkers, and Treatment

Detalles Bibliográficos
Autores principales:	Cheng, Baoli, Hoeft, Andreas H., Book, Malte, Shu, Qiang, Pastores, Stephen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365376/ https://www.ncbi.nlm.nih.gov/pubmed/25834828 http://dx.doi.org/10.1155/2015/846935

Ejemplares similares

Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis
por: Weber, Stefan U, et al.
Publicado: (2008)

A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study
por: Lehmann, Lutz E, et al.
Publicado: (2009)

Inducibility of the endogenous antibiotic peptide β-defensin 2 is impaired in patients with severe sepsis
por: Book, Malte, et al.
Publicado: (2007)

Biomarkers of Sepsis
por: Agnello, Luisa, et al.
Publicado: (2023)

Biomarkers of Metabolic Disorders: Diagnostic and Prognostic Values, and Insights into the Pathogenesis
por: Hu, Cheng, et al.
Publicado: (2014)

Biomarkers and Pathogenesis of Infectious and Autoimmune Diseases
por: Rizvanov, Albert A.
Publicado: (2022)

Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS
por: Hendrickson, Carolyn M., et al.
Publicado: (2018)

Lactate as a Biomarker for Sepsis Prognosis?
por: Kang, Ha Eun, et al.
Publicado: (2016)

Presepsin: A Promising Biomarker for Sepsis
por: Azim, Afzal
Publicado: (2021)

Sepsis-Induced Brain Dysfunction: Pathogenesis, Diagnosis, and Treatment
por: Pan, Shangwen, et al.
Publicado: (2022)

Sepsis: Evidence-based pathogenesis and treatment
por: Pravda, Jay
Publicado: (2021)

Use of biomarkers in sepsis: many questions, few answers
por: Póvoa, Pedro, et al.
Publicado: (2013)

Histidine-rich glycoprotein as an excellent biomarker for sepsis and beyond
por: Nishibori, Masahiro, et al.
Publicado: (2018)

Pathogenesis of Sepsis
por: van Engelen, Tjitske S. R., et al.
Publicado: (2017)

Can we consider procalcitonin as a consolidated biomarker in sepsis management?
por: Garcia-de-Lorenzo, A., et al.
Publicado: (2015)

What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?
por: Maksymowych, Walter P
Publicado: (2009)

New Strategies for Treatment of Sepsis
por: Mirijello, Antonio, et al.
Publicado: (2020)

State of Globe: Neutrophil CD64: Is It a Reliable Biomarker for Sepsis?
por: Ajmani, Sajal, et al.
Publicado: (2018)

Diabetic Retinopathy: From Pathogenesis to Treatment
por: Chakrabarti, Subrata
Publicado: (2007)

Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
por: Miggiano, Riccardo, et al.
Publicado: (2020)

Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers
por: Raimondo, Annunziata, et al.
Publicado: (2022)

New perspectives for the treatment of the patient with sepsis
por: Cárnio, Evelin Capellari
Publicado: (2019)

Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis
por: Luo, Gan, et al.
Publicado: (2021)

Late mortality after sepsis
por: Brett, Stephen J
Publicado: (2016)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
por: Honore, Patrick M., et al.
Publicado: (2020)

Lyme Borreliosis: From Pathogenesis to Diagnosis and Treatment
por: Zajkowska, Joanna, et al.
Publicado: (2012)

Combat Diabetic Nephropathy: From Pathogenesis to Treatment
por: Gohda, Tomohito, et al.
Publicado: (2014)

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
por: Martínez-Chantar, Maria L., et al.
Publicado: (2020)

Urine: A Lens for Asthma Pathogenesis and Treatment?
por: Peebles, R. Stokes
Publicado: (2021)

Implication of Interleukin Family in Cancer Pathogenesis and Treatment
por: Gonzalez-Aparicio, Manuela, et al.
Publicado: (2021)

Molecular Research on Migraine: From Pathogenesis to Treatment
por: Tuttolomondo, Antonino, et al.
Publicado: (2023)

From Pathogenesis to Treatment—New Perspectives in Rheumatology
por: Rezus, Elena, et al.
Publicado: (2023)

Neurovascular Disorders: Novel Perspectives on Pathogenesis, Diagnosis, and Treatment
por: Hasan, David, et al.
Publicado: (2016)

Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle: The Limiting Acute Kidney Injury Progression In Sepsis Trial
por: Gómez, Hernando, et al.
Publicado: (2023)

The impact of diabetes on the pathogenesis of sepsis
por: Koh, G. C. K. W., et al.
Publicado: (2011)

Molecular mechanisms in the pathogenesis of sepsis
por: Pop-Began, V, et al.
Publicado: (2014)

Identifying the Patient at Risk for Acute Kidney Injury: Pediatric Sepsis Biomarker Risk Model Study
por: Gien, Jason, et al.
Publicado: (2020)

Eosinophil count and neutrophil-to-lymphocyte count ratio as biomarkers for predicting early-onset neonatal sepsis
por: Lee, Jang Hoon
Publicado: (2019)

New Insights into Pathogenesis, Diagnosis, and Treatment of Pancreatic Disorders
por: Rydzewska, Grazyna, et al.
Publicado: (2013)

Tuberculosis of craniovertebral junction: Role of facets in pathogenesis and treatment
por: Goel, Atul
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2me1lk2ubds1p1ie2evnlp3alt